Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2026-01-13 @ 12:18 PM
Study NCT ID:
NCT05523895
Status:
COMPLETED
Last Update Posted:
2025-08-24
First Post:
2022-08-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder
Sponsor:
ACADIA Pharmaceuticals Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ACP-103-069
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None